trending Market Intelligence /marketintelligence/en/news-insights/trending/Fhvj134g-PU9ZDoPGcpDcg2 content esgSubNav
In This List

Flexion Therapeutics chief medical officer resigns; replacement named

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Flexion Therapeutics chief medical officer resigns; replacement named

Flexion Therapeutics Inc. tapped Scott Kelley to replace Yamo Deniz who is stepping down as chief medical officer.

Kelley was previously serving as Flexion's vice president of medical affairs. He joined the company from Sanofi, where he held the same position.

Deniz joined Flexion from Sanofi's specialty care unit Sanofi Genzyme in April.